Alphamab Oncology(HK:9966)
HK$6.15-0.09 (-1.52%)
HK:9966
Alphamab Oncology financials statements
HK$6.15
At close:-0.09 (-1.52%)
Want to see HK:9966 full AI Analyst Report?
Alphamab Oncology (9966) Financial Statements
2 Followers
Alphamab Oncology Financial Overview
Alphamab Oncology's market cap is currently ¥6.09B. The company's EPS TTM is ¥-0.17; its P/E ratio is -30.44; Alphamab Oncology has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | ¥ 551.58M | ¥ 640.08M | ¥ 218.77M | ¥ 166.84M | ¥ 146.02M |
| Gross Profit | ¥ 426.67M | ¥ 579.77M | ¥ 163.54M | ¥ 122.64M | ¥ 142.99M |
| Operating Income | ¥ -149.32M | ¥ 101.01M | ¥ -305.55M | ¥ -432.37M | ¥ -415.62M |
| EBITDA | ¥ -84.64M | ¥ 178.04M | ¥ -129.30M | ¥ -377.18M | ¥ -358.13M |
| Net Income | ¥ -110.99M | ¥ 166.34M | ¥ -210.59M | ¥ -325.72M | ¥ -412.42M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | ¥ 1.35B | ¥ 1.57B | ¥ 1.41B | ¥ 1.35B | ¥ 1.99B |
| Total Assets | ¥ 2.10B | ¥ 2.24B | ¥ 2.14B | ¥ 2.12B | ¥ 2.71B |
| Total Debt | ¥ 123.03M | ¥ 185.96M | ¥ 257.08M | ¥ 345.39M | ¥ 637.27M |
| Net Debt | ¥ -135.79M | ¥ -926.16M | ¥ -828.91M | ¥ -723.80M | ¥ -166.04M |
| Total Liabilities | ¥ 386.33M | ¥ 409.87M | ¥ 465.00M | ¥ 559.86M | ¥ 834.80M |
| Stockholders' Equity | ¥ 1.71B | ¥ 1.83B | ¥ 1.67B | ¥ 1.56B | ¥ 1.87B |
| Cash Flow | |||||
| Free Cash Flow | ¥ -153.48M | ¥ 190.56M | ¥ -239.02M | ¥ -429.96M | ¥ -478.72M |
| Operating Cash Flow | ¥ -121.89M | ¥ 212.34M | ¥ -202.84M | ¥ -300.31M | ¥ -320.60M |
| Investing Cash Flow | ¥ -628.85M | ¥ -92.93M | ¥ -18.11M | ¥ 850.76M | ¥ 574.26M |
| Financing Cash Flow | ¥ -98.31M | ¥ -98.96M | ¥ 218.07M | ¥ -310.90M | ¥ 363.90M |
Currency in CNY
